Humana Inc. (NYSE:HUM) was down 7.6% during mid-day trading on Thursday . The company traded as low as $160.97 and last traded at $166.28, with a volume of 2,172,837 shares traded. The stock had previously closed at $179.98.

A number of equities research analysts have issued reports on HUM shares. Zacks Investment Research downgraded shares of Humana from a “hold” rating to a “sell” rating in a research report on Tuesday, April 12th. Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a research report on Tuesday, April 5th. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Wolfe Research started coverage on shares of Humana in a research report on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price objective for the company. Finally, Stifel Nicolaus upped their price objective on shares of Humana from $209.00 to $220.00 and gave the stock a “buy” rating in a research report on Thursday, May 5th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. Humana presently has a consensus rating of “Hold” and an average price target of $210.60.

The stock has a 50 day moving average of $181.12 and a 200-day moving average of $175.78. The stock has a market cap of $24.25 billion and a price-to-earnings ratio of 22.69.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.81 by $0.05. The firm earned $13.80 billion during the quarter, compared to analysts’ expectations of $13.80 billion. The firm’s quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the firm posted $2.58 earnings per share. On average, equities analysts anticipate that Humana Inc. will post $8.87 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be issued a $0.29 dividend. The ex-dividend date is Tuesday, June 28th. This represents a $1.16 annualized dividend and a yield of 0.71%.

Other hedge funds and institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Humana by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 8,460,931 shares of the insurance provider’s stock valued at $1,510,361,000 after buying an additional 181,672 shares during the period. Morgan Stanley boosted its position in shares of Humana by 68.6% in the fourth quarter. Morgan Stanley now owns 1,347,032 shares of the insurance provider’s stock valued at $240,459,000 after buying an additional 547,940 shares during the period. Whitebox Advisors LLC boosted its position in shares of Humana by 282.1% in the fourth quarter. Whitebox Advisors LLC now owns 250,507 shares of the insurance provider’s stock valued at $44,718,000 after buying an additional 184,940 shares during the period. Mizuho Trust & Banking Co. Ltd. boosted its position in shares of Humana by 0.7% in the fourth quarter. Mizuho Trust & Banking Co. Ltd. now owns 226,737 shares of the insurance provider’s stock valued at $40,586,000 after buying an additional 1,625 shares during the period. Finally, State of Wisconsin Investment Board boosted its position in shares of Humana by 1.0% in the fourth quarter. State of Wisconsin Investment Board now owns 208,539 shares of the insurance provider’s stock valued at $37,226,000 after buying an additional 2,040 shares during the period.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.